FAQ/Help |
Calendar |
Search |
Today's Posts |
07-24-2017, 01:50 PM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
Endpoints News Mitsubishi Tanabe to Buy Parkinson's Disease Drugs Firm NeuroDerm for $1.1B Genetic Engineering & Biotechnology News â??We believe that this transaction will yield important benefits for NeuroDerm's shareholders and the Parkinson's disease patients that urgently need new therapies,â?? stated Oded S. Lieberman, Ph.D., CEO of NeuroDerm. â??MTPC has demonstrated development ... Mitsubishi Tanabe bags NeuroDerm and its PhIII Parkinson's program for $1.1BEndpoints News Why NeuroDerm Ltd Acquired a Higher Price TodayMadison.com Mitsubishi Tanabe to buy Israel's NeuroDerm for $1.1 bnMedical Xpress The Jewish Press - JewishPress.com -The Times of Israel -BioPharma Dive all 32 news articles » More... |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Cell Death in Parkinson’s Disease Associated With New Genetic Mutation | Parkinson's Disease | |||
Parkinson's Disease Genetic Mutation Databases | Parkinson's Disease | |||
Researchers Firm-Up Evidence For Role Of Mitochondria In Parkinson's Disease | Parkinson's Disease |